79 related articles for article (PubMed ID: 6319301)
1. Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analogues.
Matsui T; Nakao Y; Kobayashi N; Kishihara M; Ishizuka S; Watanabe S; Fujita T
Int J Cancer; 1984 Feb; 33(2):193-202. PubMed ID: 6319301
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
[TBL] [Abstract][Full Text] [Related]
3. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
4. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets.
Matsui T; Nakao Y; Koizumi T; Nakagawa T; Fujita T
Life Sci; 1985 Jul; 37(1):95-101. PubMed ID: 2989641
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
Reichel H; Koeffler HP; Norman AW
Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
[TBL] [Abstract][Full Text] [Related]
7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of vitamin D-induced human leukemia cell-line maturation.
Bar-Shavit Z; Kahn AJ; Stone KR; Trial J; Hilliard T; Reitsma PH; Teitelbaum SL
Endocrinology; 1986 Feb; 118(2):679-86. PubMed ID: 3753676
[TBL] [Abstract][Full Text] [Related]
11. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
Itin PH; Pittelkow MR; Kumar R
Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
[TBL] [Abstract][Full Text] [Related]
13. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
14. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.
Tanaka H; Abe E; Miyaura C; Shiina Y; Suda T
Biochem Biophys Res Commun; 1983 Nov; 117(1):86-92. PubMed ID: 6581807
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
16. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
18. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia.
Abe J; Morikawa M; Miyamoto K; Kaiho S; Fukushima M; Miyaura C; Abe E; Suda T; Nishii Y
FEBS Lett; 1987 Dec; 226(1):58-62. PubMed ID: 2826255
[TBL] [Abstract][Full Text] [Related]
19. A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3.
Godyn JJ; Xu H; Zhang F; Kolla S; Studzinski GP
Cell Prolif; 1994 Jan; 27(1):37-46. PubMed ID: 10465025
[TBL] [Abstract][Full Text] [Related]
20. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]